Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00557206 · ClinicalTrials.gov registry record · Phase 2
Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer
A Phase 2 study, sponsored by Minneapolis Veterans Affairs Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00557206 is a Phase 2 study that was terminated before completion, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 35 participants.
The verdict
NCT00557206, a Phase 2 study, was terminated before completion, sponsored by Minneapolis Veterans Affairs Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
Patient receiving oxaliplatin and docetaxel will have longer progression free survival than those patients receiving standard care.
Interventions
- DRUG Oxaliplatin and Docetaxel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00557206
The ClinicalTrials.gov registry entry for NCT00557206 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Veterans Affairs Medical Center, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxaliplatin and Docetaxel is the first listed.
NCT00557206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00557206 about?
NCT00557206 is a clinical study titled "Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer". Patient receiving oxaliplatin and docetaxel will have longer progression free survival than those patients receiving standard care.
What is the current status of trial NCT00557206?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2005-04. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00557206?
The interventions under investigation include: Oxaliplatin and Docetaxel (DRUG).
Who is sponsoring clinical trial NCT00557206?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.